We are live on ! Find out more
STOK icon

Stoke Therapeutics

67 hedge funds and large institutions have $796M invested in Stoke Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 15

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

5% more funds holding

Funds holding: 6467 (+3)

3.24% more ownership

Funds ownership: 102.3%105.54% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

16% less capital invested

Capital invested by funds: $948M → $796M (-$152M)

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
29
Reduced
15
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.31M +$583K +23,581 +70%
SFM
27
Sphera Funds Management
Israel
$624K -$5.66M -229,126 -89%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$592K +$286K +11,589 +81%
TD Asset Management
29
TD Asset Management
Ontario, Canada
$510K +$59.3K +2,400 +12%
Wells Fargo
30
Wells Fargo
California
$486K +$78.6K +3,180 +18%
Goldman Sachs
31
Goldman Sachs
New York
$480K -$1.16M -47,017 -69%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$463K +$303K +12,279 +155%
BC
33
Birchview Capital
Vermont
$458K +$494K +20,000 New
Citadel Advisors
34
Citadel Advisors
Florida
$432K +$208K +8,400 +80%
AllianceBernstein
35
AllianceBernstein
Tennessee
$396K +$427K +17,300 New
Swiss National Bank
36
Swiss National Bank
Switzerland
$357K
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$331K
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$323K +$4.94K +200 +1%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$295K +$318K +12,861 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$243K +$262K +10,603 New
AIG
41
American International Group
New York
$231K +$107K +4,337 +76%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$220K
MIM
43
MetLife Investment Management
New Jersey
$179K +$75.4K +3,050 +64%
Citigroup
44
Citigroup
New York
$165K +$69.2K +2,800 +64%
SG Americas Securities
45
SG Americas Securities
New York
$155K +$66.5K +2,691 +66%
Barclays
46
Barclays
United Kingdom
$142K -$89.9K -3,638 -37%
Deutsche Bank
47
Deutsche Bank
Germany
$135K +$65.7K +2,659 +82%
Bank of America
48
Bank of America
North Carolina
$134K +$55.2K +2,236 +62%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$127K +$52.4K +2,120 +62%
JP Morgan Chase
50
JP Morgan Chase
New York
$126K +$61.4K +2,486 +82%

STOK Hedge Fund Activity: Q1 2020 in Review

67 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2020, worth a combined $796M — down 16% from $948M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new STOK positions and 9 closed out — a net gain of 3 holders — while 29 added to existing stakes and 15 trimmed.

The largest buyer was Redmile Group, adding an estimated $28.3M. The largest seller was Janus Henderson Group, cutting an estimated $14.5M.

  • 67 institutional investors held Stoke Therapeutics (STOK) as of Q1 2020, up from 64 in Q4 2019.
  • Funds reported $796M of Stoke Therapeutics stock for Q1 2020, down 16% quarter-over-quarter.
  • 12 funds opened new Stoke Therapeutics positions in Q1 2020 and 9 closed out, a net change of +3 holders.
  • The largest Stoke Therapeutics buyer in Q1 2020 was Redmile Group, an estimated $28.3M added.
  • The largest Stoke Therapeutics seller in Q1 2020 was Janus Henderson Group, an estimated $14.5M sold.

Based on aggregated 13F filings for Q1 2020.